期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Low glucose metabolism in hepatocellular carcinoma with GPC3 expression 被引量:3
1
作者 You-cai Li chuan-sheng Yang +4 位作者 Wen-Lan Zhou Hong-sheng Li Yan-jiang Han Quan-shi Wang Hu-bing Wu 《World Journal of Gastroenterology》 SCIE CAS 2018年第4期494-503,共10页
AIM To investigate the relationship between glucose metabolism and glypican-3(GPc3)expression in hepatocellular carcinoma(Hcc).METHODSImmunohistochemical staining of pathological samples for GPc3 and glucose transport... AIM To investigate the relationship between glucose metabolism and glypican-3(GPc3)expression in hepatocellular carcinoma(Hcc).METHODSImmunohistochemical staining of pathological samples for GPc3 and glucose transporter 1(GLUT1),and whole-body ^(18)F-FDG PET/c T for measuring tumour glucose uptake were performed in 55 newly diagnosed Hcc patients.The maximum standard uptake value(s UVmax)and tumour-to-non-tumourous liver uptake(T/NT)ratio were used to quantify ^(18)F-FDG uptake.In vitro ^(18)F-FDG uptake assay of GPc3-expressing Hep G2 and non-GPc3-expressing RH7777 cel ls was used to examine the effect of GPc3 in cellular glucose metabolism.The relationships between GPc3 expression and ^(18)F-FDG uptake,GLUT1 expression,tumour differentiation,and other clinical indicators were analysed using spearman rank correlation,univariateand multiple logistic regression analyses.RESULTSPositive GPc3 expression was observed in 67.3%of Hcc patients,including 75.0%of those with well or moderately differentiated Hcc and 36.4%of those with poorly differentiated Hcc.There was an inverse relationship between GPc3 expression and s UVmax(Spearman correlation coefficient=-0.281,P=0.038)and a positive relationship between GLUT1 expression and sU Vmax(Spearman correlation coefficient=0.681,P<0.001)in patients with Hcc.Univariate analysis showed that two glucose metabolic parameters(sU Vmax and T/NT ratio),tumour differentiation,lymph node metastasis,and TNM stage were all significantly associated with GPc3 expression(P<0.05),whereas GLUT1 expression,sex,age,tumour size,intrahepatic lesion number,and distant metastasis showed no statistical association(P>0.05).Further multivariate analysis revealed that only the T/N ratio was significantly correlated with GPC3 expression in patients with Hcc(P<0.05).In vitro assay revealed that the uptake of ^(18)F-FDG in GPc3-expressing HepG2 cells was significantly lower than that of non-GPc3-expressing RH7777 cells(t=-20.352,P<0.001).CONCLUSIONThe present study demonstrated that GPc3 expression is inversely associated with glucose metabolism,suggesting that GPc3 may play a role in regulating glucose metabolism in Hcc. 展开更多
关键词 HEPAtoCELLULAR carcinoma GLYPICAN-3 18F-FDG Maximum standard UPTAKE value T/NT ratio GLUCOSE metabolism GLUCOSE TRANSPORTER 1
下载PDF
IGF-1/IGFBP-3摩尔比值在矮身材患儿重组人生长激素治疗时的变化研究
2
作者 和秀梅 吴虹林 +1 位作者 梁谊佳 何玺玉 《标记免疫分析与临床》 CAS 2023年第5期763-769,共7页
目的观察不同病因矮身材患儿用重组人生长激素(rhGH)治疗1年期间IGF-1/IGFBP-3摩尔比值变化,为其评价rhGH治疗效果及安全性提供理论依据。方法研究对象为2017年5月至2022年11月就诊于我院门诊,随访1年且临床资料完整的67例矮身材患儿[... 目的观察不同病因矮身材患儿用重组人生长激素(rhGH)治疗1年期间IGF-1/IGFBP-3摩尔比值变化,为其评价rhGH治疗效果及安全性提供理论依据。方法研究对象为2017年5月至2022年11月就诊于我院门诊,随访1年且临床资料完整的67例矮身材患儿[小于胎龄儿(SGA)12例、生长激素缺乏症(GHD)18例和特发性矮身材(ISS)37例]。分别于初始治疗(治疗0月),治疗3、6、9、12月,记录3组患儿身高、体重、rhGH治疗相关不良反应事件,同时测定IGF-1水平、IGFBP-3水平,并计算IGF-1/IGFBP-3摩尔比值。同时将我院儿童保健门诊0~13岁正常健康体检儿童(247名)作为对照人群,收集临床资料,测定IGF-1、IGFBP-3水平,计算IGF-1/IGFBP-3摩尔比值。结果矮身材患儿的IGF-1/IGFBP-3摩尔比值与IGF-1水平呈正相关(r=0.843,P<0.001);IGF-1/IGFBP-3摩尔比值SDS与IGF-1SDS水平呈正相关(r=0.773,P<0.001);rhGH治疗1年期间,SGA、GHD及ISS患儿的IGF-1/IGFBP-3摩尔比值与IGF-1水平出现相应变化,且变化趋势相同,说明IGF-1/IGFBP-3摩尔比值也可以是评价矮身材rhGH治疗疗效的一个生物标志物。且当IGF-1水平超过2 SDS时,IGF-1/IGFBP-3摩尔比值相对稳定,未发现不良反应事件,表明IGF-1/IGFBP-3摩尔比值在rhGH治疗安全性评估中具有合理性。结论IGF-1/IGFBP-3摩尔比值是评价矮身材rhGH治疗的一个生物标志物;rhGH治疗期间,IGF-1/IGFBP-3摩尔比值在rhGH疗效和安全性评估中具有一定科学依据。 展开更多
关键词 矮身材 重组人生长激素 IGF-1 IGF-1/IGFBP-3摩尔比值
下载PDF
重组人生长激素对特发性矮小症儿童血清IGF-1/IGFBP-3摩尔比的影响及其临床意义
3
作者 张静静 贾媛媛 +1 位作者 胡苗苗 成胜权 《东南大学学报(医学版)》 CAS 2023年第5期681-687,共7页
目的:探讨重组人生长激素(rhGH)对特发性矮小症(ISS)儿童血清胰岛素样生长因子-1(IGF-1)/IGF结合蛋白-3(IGFBP-3)摩尔比的影响及临床意义。方法:收集我院2016年6月至2020年6月收治的132例学龄期ISS儿童的临床和实验室记录进行回顾性分析... 目的:探讨重组人生长激素(rhGH)对特发性矮小症(ISS)儿童血清胰岛素样生长因子-1(IGF-1)/IGF结合蛋白-3(IGFBP-3)摩尔比的影响及临床意义。方法:收集我院2016年6月至2020年6月收治的132例学龄期ISS儿童的临床和实验室记录进行回顾性分析,所有儿童接受至少2年的rhGH治疗。采用化学发光法测定血清IGF-1和IGFBP-3浓度,并计算摩尔比。rhGH治疗前后数据差值(Δ)=治疗后值-治疗前值。rhGH治疗1年后Δ身高标准差分值(SDS)<0.3定义为治疗反应不良,Δ身高SDS≥0.3定义为治疗反应良好。结果:与基线相比,rhGH治疗1年和2年身高SDS、IGF-1 SDS、IGFBP-3 SDS以及IGF-1/IGFBP-3摩尔比SDS均增加(P<0.05)。rhGH治疗反应不良的学龄期ISS儿童基线时的实际年龄、骨龄明显高于反应良好儿童,同时IGF-1/IGFBP-3摩尔比和IGF-1/IGFBP-3摩尔比SDS明显低于反应良好儿童(P<0.05)。经多因素Logistic回归分析,基线时IGF-1/IGFBP-3摩尔比SDS较低是rhGH治疗反应不良的独立危险因素(P<0.001)。rhGH治疗1年或2年后的Δ身高SDS与ΔIGF-1/IGFBP-3摩尔比、ΔIGF-1/IGFBP-3摩尔比SDS呈正相关(P<0.05)。进一步校正作为协变量的基线身高后,治疗2年后Δ身高SDS与ΔIGF-1/IGFBP-3摩尔比SDS呈正相关(P<0.05)。结论:血清IGF-1/IGFBP-3摩尔比SDS与rhGH治疗后身高增加反应相关,可能适合作为预测学龄期ISS儿童接受rhGH治疗后身高反应的生物标志物。 展开更多
关键词 重组人生长激素 特发性矮小症 胰岛素样生长因子-1/胰岛素样生长因子结合蛋白-3摩尔比 身高标准差分值
下载PDF
稀土金属熔盐电解炉温度自动控制 被引量:1
4
作者 李建中 《江西有色金属》 2000年第2期43-46,共4页
介绍了采用单片微机控制技术 ,实现熔盐电解炉炉温自动控制的方法。实验表明 :在稀土金属电解生产中实现炉温自动控制 ,可提高产品质量和产量、降低生产成本、减轻劳动强度 ,以及提高企业现代化管理水平。
关键词 稀土金属 熔盐电解炉 温度自动控制
下载PDF
The precursor phase composition of iron catalyst and discovery of FeO based catalyst for ammonia synthesis 被引量:9
5
作者 刘化章 李小年 《Science China Chemistry》 SCIE EI CAS 1995年第5期529-537,共9页
The relationship between the activity and the precursor phase composition of the molten iron catalyst for ammonia synthesis has been studied with high pressure testing equipment and XRD. A humped curve between the act... The relationship between the activity and the precursor phase composition of the molten iron catalyst for ammonia synthesis has been studied with high pressure testing equipment and XRD. A humped curve between the activity and Fe2+/Fe3+ has been obtained. It is found that the unicity of the iron oxidate phase in precursor is an essential condition of the high activity of the iron catalyst and that the uniform distribution of the adominant phase and the promoters is the key to preparing a catalyst with better performance The humped curve is interpreted using the ratio f of the phase compositions in precursor. A new idea has been obtained that the activity change of the molten iron catalyst depends essentially on the molecule ratio of the different iron oxidates in precursor under the certain promoters, and it is found that the FeO based catalyst for ammonia synthesis with Wustite phase structure (Fe1-xO, 0.04≤x≤0.10) has the highest activity of all the molten iron catalysts for ammonia synthesis. 展开更多
关键词 AMMONIA synthesis CATALYST PRECURSOR phase composition Fe1-xO (Wustite) molecule ratio f iron ratio R (Fe2+/Fe3+).
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部